Nivolumab plus ipilimumab in advanced salivary gland cancer: a phase 2 trial
Joris L. Vos, Bharat Burman, Swati Jain, Conall Fitzgerald, Eric J. Sherman, Lara Dunn, James Fetten, Loren S. Michel, Anuja Kriplani, Kenneth Ng, Juliana Eng, Vatche Tchekmedyian, Sofia Haque, Nora Katabi, Fengshen Kuo, Catherine Y. Han, Zaineb Nadeem, Wei Yang, Vladimir Makarov, Raghvendra M. Srivastava, Irina Ostrovnaya, Manu Prasad, Charlotte L. Zuur, Nadeem Riaz, David G. Pfister, Christopher A. Klebanoff, Timothy A. Chan, Alan L. Ho, Luc G.T. Morris
Topics & Concepts
IpilimumabNivolumabSalivary gland cancerMedicineSalivary glandOncologyInternal medicineCancerImmunotherapySalivary Gland Tumors Diagnosis and TreatmentCancer Immunotherapy and BiomarkersColorectal and Anal Carcinomas